OLK 26.08 (+0.31%)
US6807101000Medical Diagnostics & ResearchDiagnostics & Research

Olink Holding (OLK) Competitor Comparison

We are evaluating the key criteria listed to compare Olink Holding (OLK) against its competitors in the Diagnostics & Research industry.

Performance 3 years - OLK ranking 19 / 58

These are the competitors of Olink Holding in the industry Diagnostics & Research ranked by performance 3 years
1. Lantheus Holdings LNTH
302.4
2. Meridian Bioscience VIVO
246.63
3. RadNet RDNT
128.56
4. Medpace Holdings MEDP
82.52
5. Heska HSKA
41.31
6. PerkinElmer PKI
21.19
7. Icon ICLR
15.06
8. Ortho Clinical Diagnostics Holdings OCDX
13.74
9. Thermo Fisher Scientific TMO
6.6
10. Natera NTRA
4.62
11. Quest Diagnostics DGX
-0.59
12. Danaher DHR
-6.54
13. IQVIA Holdings IQV
-8.94
14. Mettler-Toledo MTD
-13.89
15. Laboratory Corp of America Holdings LH
-14.54
16. Qiagen QGEN
-15.28
17. Myriad Genetics MYGN
-16.9
18. Syneos Health SYNH
-19.01
19. Olink Holding OLK
-22.2
20. Agilent Technologies A
-22.71
21. Waters WAT
-22.97
22. Sera Prognostics SERA
-23.48
23. Bioventus BVS
-24.53
24. IDEXX Laboratories IDXX
-27.14
25. Sotera Health SHC
-32.61
26. Anixa Biosciences ANIX
-33
27. Exact Sciences EXAS
-36.91
28. Trinity Biotech TRIB
-38.7
29. DexCom DXCM
-48.65
30. Charles River Laboratories CRL
-55.14
31. National Research NRC
-55.43
32. CareDx CDNA
-58.74
33. Twist Bioscience TWST
-61.32
34. Neogen NEOG
-62.27
35. Global Cord Blood CO
-67.25
36. Enzo Biochem ENZ
-68.29
37. NeoGenomics NEO
-68.76
38. Psychemedics PMD
-70.2
39. Illumina ILMN
-71.18
40. Personalis PSNL
-73.71
41. MaxCyte MXCT
-73.97
42. Fulgent Genetics FLGT
-76.14
43. Exagen XGN
-78.04
44. MDxHealth MDXH
-78.44
45. bioAffinity Technologies BIAF
-79.29
46. Guardant Health GH
-79.44
47. Biodesix BDSX
-82.01
48. Interpace Biosciences IDXG
-83.09
49. Co-Diagnostics CODX
-87.54
50. Organovo Holdings ONVO
-89.19
51. Precipio PRPO
-90.1
52. Neuronetics STIM
-91.07
53. DarioHealth DRIO
-93.77
54. Pacific Biosciences of California PACB
-93.91
55. Inotiv NOTV
-95.05
56. Prenetics Global PRE
-96.01
57. SeqLL SQL
-96.56
58. Aspira Womens Health AWH
-98.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.